Evidence map›Paper›PMID 28043113›Full record

ArticleInternational neurourology journal2016

Long-term Outcome of the Retrourethral Transobturator Male Sling After Transurethral Resection of the Prostate.

Alexander Kretschmer, Alexander Buchner, Benedikt Leitl, Markus Grabbert, Anne Sommer, Wael Khoder, Christian Gozzi, Christian G Stief, Ricarda M Bauer

Open access · diamondAbstract read
In one paragraph

Article in International neurourology journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. AdVance male sling.Translational andrology and urology · 2017
    Review
  8. Proposal of a new way to evaluate the external sphincter function prior male sling surgey.International braz j urol : official journal of the Brazilian Society of Urology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Alexander KretschmerDepartment of Urology, Ludwig-Maximilians-University, Munich, Germany.ORCID 0000-0002-6511-4354
Alexander BuchnerDepartment of Urology, Ludwig-Maximilians-University, Munich, Germany.ORCID 0000-0001-7895-7070
Benedikt LeitlDepartment of Urology, Ludwig-Maximilians-University, Munich, Germany.ORCID 0000-0002-5020-5405
Markus GrabbertDepartment of Urology, Ludwig-Maximilians-University, Munich, Germany.ORCID 0000-0002-7059-6124
Anne SommerDepartment of Urology, Ludwig-Maximilians-University, Munich, Germany.ORCID 0000-0003-3913-1035
Wael KhoderDepartment of Urology, Johann-Wolfgang Goethe University, Frankfurt, Germany.ORCID 0000-0002-8813-8981
Christian GozziDepartment of Urology, Marienklinik, Bolzano, Italy.ORCID 0000-0001-7544-5942
Christian G StiefDepartment of Urology, Ludwig-Maximilians-University, Munich, Germany.ORCID 0000-0003-3291-9460
Ricarda M BauerDepartment of Urology, Ludwig-Maximilians-University, Munich, Germany.ORCID 0000-0001-9911-1728
Ludwig-Maximilians-Universität München · DEGoethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate long-term outcomes of AdVance and AdVanceXP male slings in patients with persistent stress urinary incontinence (SUI) after transurethral resection of the prostate (TURP).

methodsA total of 18 consecutive patients received AdVance (n=14) or AdVanceXP (n=4) male sling implantation between 2007 and 2013. Continence was determined by pad use, 24-hour pad testing and validated questionnaires (International Consultation on Incontinence Questionnaire Short Form, ICIQ-SF). Quality of life was evaluated by International Quality of Life (IQoL) score. Patient satisfaction was measured with patient's global impression of improvement score. Cure was defined as 0-5 g in the 24-hour pad test. Statistical analysis included Fisher exact and Wilcoxon test (P<0.05).

resultsFollow-up was available for 15 patients who underwent further analysis. After a median follow-up of 70 months (range, 18-83 months), mean daily pad usage was 1.8±2.1 pads (P=0.015 vs. baseline level). Mean IQoL score was 66.4±31.6 (P=0.050 vs. baseline level), and mean ICIQ-SF score was 9.5±6.6 (P=0.077 vs. baseline level). Based on 24-hour pad testing, mean daily urine loss was 31.2±64.5 g (median, 0 g; range, 0-209 g). Cure rate was 46.7%, and cure-and-improved rate was 60.0%. Assessing predictive features for success, better results were found in patients who needed up to 4 pads preoperatively (P=0.041) as well as for patients ≤71 years at the time of implantation (P=0.041).

conclusionsThe findings indicate that AdVance and AdVanceXP implantation can be performed effectively and safely in men suffering from SUI after TURP. However, long-term success rates seem to be lower compared to SUI after radical prostatectomy and patients should be counseled accordingly.

Indexed as

ComplicationsSuburethral SlingsTransurethral Resection of the ProstateUrinary Stress, Incontinence

Identifiers

PMID28043113
PMCPMC5209579
OpenAlexW2565855603

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.